Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,855 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CpG ODN (K3)-toll-like receptor 9 agonist-induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study.
Otsuka T, Nishida S, Shibahara T, Temizoz B, Hamaguchi M, Shiroyama T, Kimura K, Miyake K, Hirata H, Mizuno Y, Yagita M, Manabe Y, Kuroda E, Takeda Y, Kida H, Ishii KJ, Kumanogoh A. Otsuka T, et al. Among authors: nishida s. BMC Cancer. 2022 Jul 7;22(1):744. doi: 10.1186/s12885-022-09818-4. BMC Cancer. 2022. PMID: 35799134 Free PMC article. Clinical Trial.
WT1 IgG antibody for early detection of nonsmall cell lung cancer and as its prognostic factor.
Oji Y, Kitamura Y, Kamino E, Kitano A, Sawabata N, Inoue M, Mori M, Nakatsuka S, Sakaguchi N, Miyazaki K, Nakamura M, Fukuda I, Nakamura J, Tatsumi N, Takakuwa T, Nishida S, Shirakata T, Hosen N, Tsuboi A, Nezu R, Maeda H, Oka Y, Kawase I, Aozasa K, Okumura M, Miyoshi S, Sugiyama H. Oji Y, et al. Among authors: nishida s. Int J Cancer. 2009 Jul 15;125(2):381-7. doi: 10.1002/ijc.24367. Int J Cancer. 2009. PMID: 19384943
High frequencies of less differentiated and more proliferative WT1-specific CD8+ T cells in bone marrow in tumor-bearing patients: an important role of bone marrow as a secondary lymphoid organ.
Murao A, Oka Y, Tsuboi A, Elisseeva OA, Tanaka-Harada Y, Fujiki F, Nakajima H, Nishida S, Hosen N, Shirakata T, Hashimoto N, Myoui A, Ueda T, Takeda Y, Osaki T, Enomoto T, Yoshikawa H, Kimura T, Oji Y, Kawase I, Sugiyama H. Murao A, et al. Among authors: nishida s. Cancer Sci. 2010 Apr;101(4):848-54. doi: 10.1111/j.1349-7006.2009.01468.x. Epub 2009 Dec 11. Cancer Sci. 2010. PMID: 20136847 Free PMC article.
Biased usage of T cell receptor β-chain variable region genes of Wilms' tumor gene (WT1)-specific CD8+ T cells in patients with solid tumors and healthy donors.
Morimoto S, Oka Y, Tsuboi A, Tanaka Y, Fujiki F, Nakajima H, Hosen N, Nishida S, Nakata J, Nakae Y, Maruno M, Myoui A, Enomoto T, Izumoto S, Sekimoto M, Kagawa N, Hashimoto N, Yoshimine T, Oji Y, Kumanogoh A, Sugiyama H. Morimoto S, et al. Among authors: nishida s. Cancer Sci. 2012 Mar;103(3):408-14. doi: 10.1111/j.1349-7006.2011.02163.x. Epub 2012 Jan 17. Cancer Sci. 2012. PMID: 22126448 Free PMC article.
Functional human Th17 clones with WT1-specific helper activity.
Tachino S, Fujiki F, Oka Y, Tsuboi A, Morimoto S, Lin YH, Tamanaka T, Kondo K, Nakajima H, Nishida S, Hosen N, Oji Y, Kumanogoh A, Sugiyama H. Tachino S, et al. Among authors: nishida s. Cancer Immunol Immunother. 2013 Apr;62(4):801-10. doi: 10.1007/s00262-012-1385-3. Epub 2012 Dec 29. Cancer Immunol Immunother. 2013. PMID: 23275045 Free PMC article.
Maintenance of complete remission after allogeneic stem cell transplantation in leukemia patients treated with Wilms tumor 1 peptide vaccine.
Maeda T, Hosen N, Fukushima K, Tsuboi A, Morimoto S, Matsui T, Sata H, Fujita J, Hasegawa K, Nishida S, Nakata J, Nakae Y, Takashima S, Nakajima H, Fujiki F, Tatsumi N, Kondo T, Hino M, Oji Y, Oka Y, Kanakura Y, Kumanogoh A, Sugiyama H. Maeda T, et al. Among authors: nishida s. Blood Cancer J. 2013 Aug 2;3(8):e130. doi: 10.1038/bcj.2013.29. Blood Cancer J. 2013. PMID: 23912610 Free PMC article. No abstract available.
Wilms tumor gene (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer.
Nishida S, Koido S, Takeda Y, Homma S, Komita H, Takahara A, Morita S, Ito T, Morimoto S, Hara K, Tsuboi A, Oka Y, Yanagisawa S, Toyama Y, Ikegami M, Kitagawa T, Eguchi H, Wada H, Nagano H, Nakata J, Nakae Y, Hosen N, Oji Y, Tanaka T, Kawase I, Kumanogoh A, Sakamoto J, Doki Y, Mori M, Ohkusa T, Tajiri H, Sugiyama H. Nishida S, et al. J Immunother. 2014 Feb-Mar;37(2):105-14. doi: 10.1097/CJI.0000000000000020. J Immunother. 2014. PMID: 24509173 Free PMC article. Clinical Trial.
1,855 results